Search

Your search keyword '"Parkinson´s disease"' showing total 555 results

Search Constraints

Start Over You searched for: Descriptor "Parkinson´s disease" Remove constraint Descriptor: "Parkinson´s disease"
555 results on '"Parkinson´s disease"'

Search Results

1. Associations of milk, dairy products, calcium and vitamin D intake with risk of developing Parkinson´s disease within the EPIC4ND cohort.

2. Sublingual apomorphine in the treatment of Parkinson's disease.

Catalog

Books, media, physical & digital resources

3. The therapeutic use of clonal neural stem cells in experimental Parkinson´s disease

4. Efficacy of subthalamic deep brain stimulation programming strategies for gait disorders in Parkinson's disease: a systematic review and meta-analysis.

5. ESCALA DE SONOLÊNCIA DE EPWORTH E POLISSONOGRAFIA TIPO 1 EM PACIENTES COM DOENÇA DE PARKINSON: UMA CORRELAÇÃO POSSÍVEL?

6. QUESTIONÁRIO STOP-BANG EM PACIENTES COM DOENÇA DE PARKINSON SOB INVESTIGAÇÃO DA APNEIA OBSTRUTIVA DO SONO: UMA ANÁLISE CLÍNICO-EPIDEMIOLÓGICA.

7. Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson's Disease.

8. NFKB1 variants were associated with the risk of Parkinson´s disease in male.

10. Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity

11. Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity.

12. Role of zonisamide in advanced Parkinson's disease: a randomized placebo-controlled study.

13. An examination of anxiety and its influence on health-related quality of life in Parkinson’s disease using the geriatric anxiety scale: a cross-sectional study

17. Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight.

19. Effects of curcumin to counteract levodopa-induced toxicity in zebrafish.

20. Parkinson's disease patients' perspective on telephone visits during the COVID-19 pandemic.

21. Parkinson disease with mild cognitive impairment: Domain‐specific cognitive complaints predict dementia

22. Cdk5 and aberrant cell cycle activation at the core of neurodegeneration

23. Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection.

24. PAMAM dendrimers of generation 4.5 loaded with curcumin interfere with α-synuclein aggregation

25. Probing motor dynamics at the muscle level—Acoustic myography in Parkinson's disease.

26. Trends and Sex Differences in Hospitalizations and Mortality in Parkinson's Disease in Spain (2010–2019): A Nationwide Population-Based Study.

27. Effects of MOTOmed® movement therapy on the motor function and main symptoms of patients with Parkinson’s disease: a systematic review.

28. Probing motor dynamics at the muscle level—Acoustic myography in Parkinson's disease

29. Are movement-based mindful exercises (QIGONG, TAI CHI, AND YOGA) beneficial for stroke and Parkinson’s disease? A scoping review

30. Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson´s disease.

31. Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson's Disease.

32. Exploring marine resources against neurological disorders– the neuroprotective and anti-inflammatory potential of the brown seaweed Bifurcaria bifurcata.

33. Promoting a Sustainable Digital Work Life for People with Cognitive Difficulties

34. Musikterapi i form av sång som symtomlindrande omvårdnadshandling vid Parkinsons sjukdom : en litteraturöversikt

35. A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features.

36. Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice.

37. NEGATÍVNY ÚČINOK PARKINSONOVEJ CHOROBY NA PSYCHICKÝ A SOCIÁLNY BLAHOBYT PACIENTA.

38. Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice

39. Wearable Immersive Virtual Reality Device for Promoting Physical Activity in Parkinson's Disease Patients.

40. Systematic quantitative assessment of motor function in clinically isolated REM sleep behaviour disorder: A diagnostic window into early alpha‐synucleinopathies.

41. Enfermedades neurológicas y juego.

42. 'Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease'

43. Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson's Disease.

44. Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease

45. Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease.

46. 基于蛋白相互作用网络的帕金森病 相关信号通路关键蛋白的筛选.

47. The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease.

48. Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review.

49. What's wrong with the striatal cholinergic interneurons in Parkinson's disease? Focus on intrinsic excitability.

50. Cellular Trafficking of Glutathione Transferase M2-2 Between U373MG and SHSY-S7 Cells is Mediated by Exosomes.